Proto Labs, Inc. Common stock (PRLB): Price and Financial Metrics
Today's Latest Price: $137.25 USD
Oct 23 7:00pm Add PRLB to Watchlist Sign Up
PRLB Stock Summary Price to trailing twelve month operating cash flow for PRLB is currently 31.5, higher than 87.42% of US stocks with positive operating cash flow. For PRLB, its debt to operating expenses ratio is greater than that reported by merely 9.72% of US equities we're observing. Equity multiplier, or assets relative to shareholders' equity, comes in at 1.16 for Proto Labs Inc; that's greater than it is for merely 10.76% of US stocks. Stocks that are quantitatively similar to PRLB, based on their financial statements, market capitalization, and price volatility, are APDN, DDD, BRKS, GMED, and KVHI. Visit PRLB's SEC page to see the company's official filings. To visit the company's web site, go to www.protolabs.com.
PRLB Price/Volume Stats
Proto Labs, Inc. Common stock (PRLB) Company Bio
Proto Labs manufactures computer numerical control machined, injection molded, and 3D printed custom parts for prototyping and short-run production in the medical, aerospace, computer/electronics, consumer products, industrial machinery, and other markets. The company was founded in 1999 and is based in Maple Plain, Minnesota.
PRLB Latest News Stream
All News Types
Acquisition Commentary Downgrade Earnings Guidance Down Guidance Up Mgmt Change New Coverage (Bearish) New Coverage (Bullish) Product News PT Lowered PT Set (Neutral) Rating Reiterated (Bullish) Rating Reiterated (Neutral) Upgrade
Loading, please wait...
Latest PRLB News From Around the Web
Below are the latest news stories about Proto Labs Inc that investors may wish to consider to help them evaluate PRLB as an investment opportunity.
Proto Labs, Inc. (NYSE:PRLB) just released its second-quarter report and things are looking bullish. The company beat...
Proto Labs (PRLB): Q2 Non-GAAP EPS of $0.59 beats by $0.23; GAAP EPS of $0.47 beats by $0.22.Revenue of $106.58M (-8.0% Y/Y) beats by $6.12M.Press Release...
Proto Labs ([[PRLB]] -8.3%) is down after reporting Q2 sales decline of 8% Y/Y to $106.8M, despite beating analysts’ estimates for the quarter.Revenue by segments: Injection Molding $57.89M (+4.4% Y/Y); CNC Machining $28.76M (-26% Y/Y); 3D Printing $14.24M (-6.8% Y/Y); Sheet Metal $4.67M (-14.7% Y/Y); and Others $1.02M (+19.7% Y/Y).Q2...
Shares of Proto Labs (NYSE:PRLB) fell 2% after the company reported Q2 results. Quarterly Results Earnings per share fell 16.90% over the past year to …
Investors will soon learn how the COVID-19 pandemic affected the quick-turn contract manufacturer's Q2 results.
Read More 'PRLB' Stories Here
PRLB Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.7193 seconds.